**Core Concept**
Adenosine deaminase (ADA) is an enzyme crucial for the breakdown of adenosine and deoxyadenosine, thereby maintaining normal purine metabolism. Its deficiency leads to the accumulation of toxic metabolites, which in turn cause cellular damage and immune system dysfunction.

**Why the Correct Answer is Right**
The correct answer is related to Severe Combined Immunodeficiency (SCID). ADA deficiency is a type of SCID, characterized by impaired T and B lymphocyte function. This occurs because ADA is essential for the breakdown of deoxyadenosine, which, when accumulated, is toxic to lymphocytes. The enzyme's deficiency disrupts the normal development and function of lymphocytes, leading to severe immunodeficiency.

**Why Each Wrong Option is Incorrect**
**Option A:** This option might be incorrect because ADA deficiency is not primarily associated with other types of immunodeficiency, such as X-linked agammaglobulinemia or Wiskott-Aldrich syndrome. These conditions have different underlying pathophysiology.

**Option B:** This option is incorrect because ADA deficiency is not primarily associated with autoimmune disorders, such as rheumatoid arthritis or lupus. While ADA has roles in regulating immune responses, its deficiency specifically leads to immunodeficiency rather than autoimmunity.

**Option C:** This option is incorrect because ADA deficiency is not primarily associated with metabolic disorders, such as glycogen storage disease or urea cycle disorders. These conditions have distinct underlying pathophysiology.

**Clinical Pearl / High-Yield Fact**
ADA deficiency is a form of SCID that presents with recurrent infections, failure to thrive, and impaired lymphocyte function. It is often diagnosed through enzyme assays or molecular genetic testing.

**Correct Answer:** C. Severe Combined Immunodeficiency (SCID)